Skip to content
healthcare.dev

Abiraterone Acetate

NDC 82293-001, abiraterone acetate, tablet, film coated, from Novugen Pharma (USA) LLC.

Product NDC
82293-001
Status
Listed
Labeler
Novugen Pharma (USA) LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215947
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82293-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
82293-001-1082293000110120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82293-001-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f308b463-27e4-422a-95a2-ecbbf95eee20
  • NADAC price for package 82293000110

    GET /v1/drugs/nadac/82293000110

Use it

Look up 82293-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82293-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82293-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.